CASAROTTO, DINO
 Distribuzione geografica
Continente #
NA - Nord America 3.341
EU - Europa 408
AS - Asia 226
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 3.979
Nazione #
US - Stati Uniti d'America 3.340
CN - Cina 213
SE - Svezia 121
FI - Finlandia 77
DE - Germania 62
UA - Ucraina 58
IT - Italia 40
GB - Regno Unito 27
FR - Francia 11
IN - India 8
IE - Irlanda 6
VN - Vietnam 5
BE - Belgio 4
EU - Europa 3
NL - Olanda 2
BR - Brasile 1
CA - Canada 1
Totale 3.979
Città #
Fairfield 525
Chandler 449
Woodbridge 337
Jacksonville 290
Houston 237
Wilmington 216
Seattle 202
Ann Arbor 193
Ashburn 180
Cambridge 167
Princeton 107
Beijing 77
Roxbury 44
Nanjing 42
San Diego 41
Boardman 24
Medford 23
Helsinki 21
Guangzhou 20
Des Moines 16
Shenyang 15
London 13
Nanchang 13
Hebei 12
Redwood City 12
Jiaxing 10
Washington 10
Padova 9
Norwalk 8
Dublin 6
Jinan 6
Changsha 5
Dong Ket 5
Brussels 4
Munich 4
Tianjin 4
Indiana 3
Auburn Hills 2
Borås 2
Florence 2
Haikou 2
Hanover 2
Kharkiv 2
Ningbo 2
Bad Oeynhausen 1
Bari 1
Chicago 1
Chiswick 1
Ipatinga 1
Lancaster 1
Palermo 1
Phoenix 1
Redmond 1
San Francisco 1
San Severino Marche 1
Siena 1
Taizhou 1
Verona 1
Vigonza 1
Totale 3.379
Nome #
High rejection score in the first year and risk of skin cancer in heart transplantation 129
Hancock II bioprosthesis: a glance at the microscope in mid-long-term explants 108
Surgical treatment of complete A-V canal defects in children before 3 months of age 106
THE 24-HOUR RHYTHM OF BLOOD PRESSURE DIFFERS FROM THAT OF LEG HEMODYNAMICS IN ORTHOTOPIC HEART TRANSPLANT RECIPIENTS 98
Unusual left ventricular mass. 97
Cell characterization of porcine aortic valve and decellularized leaflets repopulated with aortic valve interstitial cells: the VESALIO Project (Vitalitate Exornatum Succedaneum Aorticum Labore Ingenioso Obtenibitur) 96
Endothelin-1 and Its mRNA in the wall layers of human arteries ex vivo 96
DONOR SHORTAGE IN HEART-TRANSPLANTATION 94
De novo noncutaneous malignancies in heart transplantation: a single-centre 15-year experience and risk factor analysis 91
Hancock II porcine bioprosthesis: excellent durability at intermediate-term follow-up 91
Fibrous tissue overgrowth on Hancock mitral xenografts: a cause of late prosthetic stenosis. 90
Unexpected mechanical bileaflet valve thrombosis in mitral position: what is better to do, re-replacement or thrombolysis 90
Evolution of focal moderate (International Society for Heart and Lung Transplantation grade 2) rejection of the cardiac allograft 87
Reoperations for acute prosthetic thrombosis and pannus: an assessment of rates, relationship and risk. 87
Primary cardiac valve tumours 87
Isolation of intact aortic valve scaffolds for heart-valve bioprostheses: Extracellular matrix structure, prevention from calcification, and cell repopulation features 86
Extracorporeal photochemotherapy as adjuvant treatment of heart transplant recipients with recurrent rejection 84
Discordance between pre and post cardiac transplantat diagnosis: implications for pre and post operative decision making. 82
Surgical removal of a left atrial myxoma during pregnancy. 81
Thermal analysis characterization of aortic tissues for cardiac valve bioprostheses 80
Prosthetic replacement of the tricuspid valve: biological or mechanical? 80
Multivariate analysis of survival after malfunctioning biological and mechanical prosthesis replacement. 78
Surgical treatment of complex cardiac anomalies: the 'one and one half ventricle repair 75
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 74
Arterial switch operation after left ventricular retraining in the adult. 73
Mitral and aortic valve replacement in valvular rheumatoid heart disease. 71
Left ventricular rupture following mitral valve replacement with a Hancock bioprosthesis. 70
Surgical closure of apical ventricular septal defects through a right ventricular apical infundibulotomy 68
Histological survey of the saphenous vein before its use as autologous aortocoronary bypass graft. 68
Monoclonal gammopathy in heart transplantation: clinical significance and risk factors 66
Pulmonary atresia, intact ventricular septum, and Ebstein anomaly of the tricuspid valve. Anatomic and surgical considerations. 64
Increased Myocardial GRP94 Amounts During Sustained Atrial Fibrillation: A Protective Response? 62
Mid-term follow-up in patients with Biocor porcine bioprostheses. 62
Discordance between pre and post cardiaca transplant diagnosis: implications for pre- and post-operative decision making. 61
High rejection score in the first year and risk of skin cancer in heart transplantation 61
Pressure-dependence of the Aortic Valve Gradient 59
Case report: fibroelastoma of the papillary muscle of the mitral valve: diagnostic implications and review of the literature 58
Skin cancer in heart transplant recipients - Risk factor analysis and relevance of immunosuppressive therapy 58
Left main trunk ostial stenosis and aortic incompetence in Takayasu's arteritis 56
New trends in heart transplantation 55
Repair of congenital mitral valve dysplasia in infants and children: is it always possible? 54
Erratum: Surgical treatment of complex cardiac anomalies: The 'one and one half ventricle repair' (European Journal Cardiothoracis Surgery 22 (2002) 22 (431-437) PII: S1010794002003688) 53
Le indicazioni all'impiego di homograft e autograft nelle valvulopatie aortiche. 50
Cell composition of the human pulmonary valve: A comparative study with the aortic valve - The VESALIO* project 48
Surgical treatment of comlete A-V canal defects in children before 3 months of age 45
Long-term results (from 5 to 7 years) with the Hancock S-G-P bioprosthesis. 45
Influence of marginal donors on early results after heart transplantation. 44
Tumori cardiaci: classificazione ed epidemiologia 43
Wear tested pulmonary porcine valve: mechanical properties and ultrastructural findings. 43
Donor age greater than 50 years does not influence midterm results of heart transplantation. 43
Double criss-cross sternal wiring and chest wound infections [3] (multiple letters) 37
[Late aortic dissection after aortic valve substitution. Considerations on 5 operative cases]. 33
Aortic valve replacement with pulmonary homografts. Early experience. 33
Terapie chirurgiche e malattie delle valvole cardiache 32
Cyclosporine-based steroid-freee therapy in pediatric heart transplantation: long term results. 32
Transaortic gradient is pressure-dependent in a pulsatile model of the circulation 32
Mechanics of cryopreserved aortic and pulmonary homografts 30
Malattie del cuore e del pericardio. 29
Rupture of the posterior wall of the left heart at the atrio-ventricular groove following mitral valve replacement. 29
Influence of rejection on late graft function after heart transplantation. 26
High rejection score in the first year as a predictor of heart transplant recipients at risk of skin cancer 22
Searching for a correct method of evaluation of valve prosthesis performance. Laboratory assessment. 14
Impact of organ preservation techniques on outcome of cardiac transplantation in the era of donor pool expansion 9
Successful treatment of disseminated infection with Listeria monocytogenes in a heart transplant recipient [3] 1
Totale 4.006
Categoria #
all - tutte 10.280
article - articoli 9.788
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 492
Totale 20.560


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019467 0 0 63 4 1 5 6 40 4 82 148 114
2019/2020938 145 32 12 50 101 78 73 113 89 122 75 48
2020/2021584 18 54 19 63 31 61 21 61 102 50 75 29
2021/2022778 25 93 60 58 17 102 24 90 41 17 88 163
2022/2023692 143 97 20 110 107 93 0 35 51 3 27 6
2023/202492 15 36 41 0 0 0 0 0 0 0 0 0
Totale 4.006